The National Institute for Health and Clinical Excellence ( NICE) has reversed an earlier decision on the use of drug-eluting stents when treating coronary artery disease. Under new guidance, the organisation states that drug-eluting stents may be cost-effective for some patients. The Clinical Services Journal provides a summary of the key points.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
